Enrofloxacine injection or infusion solutions

US5998418A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Gerhard Bonse · Neunburg vorm Wald, DE
• Martin Hamm · Düsseldorf, DE
• Hanns P. Muller · Leverkusen, DE
• Arundev H. Naik · Monheim, DE
• Martin Scheer · Wuppertal, DE
• Michael Stegemann · Lenexa, US
• Oliver Vetter · Burscheid, DE

Key dates

• Filing date: Jul 7, 1997
• Grant date: Dec 7, 1999
• Expiry date: Jul 7, 2017

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel injection and infusion solutions of the following composition: PA1 a) 0.1 to 20% by weight of enrofloxacin, based on the total weight of the solution, in the form of its salts with polyhydroxycarboxylic acids or amino acids or mixtures thereof, PA1 b) polyhydroxycarboxylic acids, amino acids or mixtures thereof in 0.1 to 5 molar excess, based on enrofloxacin; PA1 c) optionally 0.1 to 30% by weight of formulation aids, based on the total weight of the solution; PA1 d) water to 100% by weight.